http://www.law360.com/ Latest articles for organization: Sayles Werbner Copyright 2009 Portfolio Media, Inc. en-US http://www.law360.com/images/headings/logo.gif http://www.law360.com/ http://www.law360.com/articles/132584 A federal judge has upheld a jury verdict awarding Johnson & Johnson subsidiary Centocor Ortho Biotech Inc. and New York University a record $1.67 billion for their claims that Abbott Laboratories' flagship arthritis drug Humira infringed their patent. http://www.law360.com/articles/132584 http://www.law360.com/articles/130453 Southwest Airlines Co. has agreed to pay $3.5 million to settle a shareholder derivative lawsuit alleging the company breached its fiduciary duty by allowing its planes to fly without performing mandatory inspections for fuselage fatigue cracking. http://www.law360.com/articles/130453 http://www.law360.com/articles/129795 A special receiver for defunct AmeriFirst Funding Inc. who brought a negligence suit against law firm Godwin Ronquillo PC and one of its former partners has seen his complaint dismissed for a second time, though a judge gave him one more chance to replead. http://www.law360.com/articles/129795 http://www.law360.com/articles/124070 Storm LLP, a firm allegedly stiffed by its client for more than $1 million in fees after winning a $72.6 million dollar malpractice verdict against Akin Gump Strauss Hauer & Feld LLP over patent litigation, has asked a federal court to step in and adjudicate the fee dispute. http://www.law360.com/articles/124070 http://www.law360.com/articles/112289 NL Industries Inc. has been hit with a $178.7 million jury verdict in a suit filed by three shareholders who claimed the lead paint manufacturer undervalued their stock and artificially drained the assets from a subsidiary they ran to manage the company’s environmental liabilities. http://www.law360.com/articles/112289 http://www.law360.com/articles/108913 A jury in the U.S. District Court for the Eastern District of Texas has hit Abbott Laboratories with possibly the largest patent verdict in U.S. history, awarding Johnson & Johnson subsidiary Centocor Inc. $1.67 billion and finding that Abbott's flagship arthritis drug Humira infringed a Centocor patent. http://www.law360.com/articles/108913 http://www.law360.com/articles/103615 A federal judge has refused Abbott Laboratories' bid to invalidate two patents in an infringement suit brought by Centocor Inc. and New York University over Abbott's flagship arthritis drug Humira. http://www.law360.com/articles/103615 http://www.law360.com/articles/101729 Johnson & Johnson subsidiary Centocor Inc. and New York University have been denied summary judgment in their patent infringement case against Abbott Laboratories over its popular arthritis drug Humira. http://www.law360.com/articles/101729 http://www.law360.com/articles/100354 Hundreds of plaintiffs have added their names to a suit against Arab Bank PLC alleging that it promotes suicide attacks and other murderous acts in Israel by funneling money to the families of bombers. http://www.law360.com/articles/100354 http://www.law360.com/articles/88746 The court overseeing a patent infringement suit over drug-eluting stent technology has stricken defendants Johnson & Johnson and Cordis Corp.'s invalidity contentions, granting a motion from plaintiff Dr. Bruce Saffran that accused the companies of burying their argument in a "haystack of references." http://www.law360.com/articles/88746 http://www.law360.com/articles/84093 Motorola Inc. and its subsidiary Symbol Technologies Inc. have resolved a lawsuit with patent-holding company Commil USA LLC over wireless network technology. http://www.law360.com/articles/84093 http://www.law360.com/articles/83454 Johnson & Johnson subsidiary Centocor Inc. and New York University have caught heat from a federal judge for their motion to compel Abbott Laboratories to produce testimony for their patent infringement case over Abbott’s popular arthritis drug Humira. http://www.law360.com/articles/83454 http://www.law360.com/articles/72553 Less than a month after a judge dismissed a similar complaint against a different unit of AT&T Inc. for failure to state a claim, Linksmart Wireless Technology LLC has filed a new patent lawsuit against AT&T Internet Services. http://www.law360.com/articles/72553 http://www.law360.com/articles/70488 AT&T Mobility LLC has been dropped from a wide-ranging lawsuit over wireless technology because the plaintiff, Linksmart Wireless Technology LLC, failed to state a claim against it. http://www.law360.com/articles/70488 http://www.law360.com/articles/63739 Shire LLC fired off its third infringement suit of the month Thursday when it sued Actavis Inc. for infringing two patents covering Shire's epilepsy drug Carbatrol. http://www.law360.com/articles/63739 http://www.law360.com/articles/61351 Drugmaker Shire LLC has sued generics makers Apotex Inc. and Nostrum Pharmaceuticals Inc. to stop them from making a generic version of Shire's popular epilepsy drug Carbatrol. http://www.law360.com/articles/61351 http://www.law360.com/articles/56096 Chip maker National Semiconductor Corp. has been hit with a lawsuit alleging that its WEBENCH online circuit design tools infringe a patent owned by eTool Patent Holdings Corp. http://www.law360.com/articles/56096 http://www.law360.com/articles/52154 Chase Medical Technologies has fallen slightly short in its bid for treble damages, months after a Texas jury unanimously found in favor of the company in a patent infringement suit over a surgical technique for repairing hearts after a heart attack. http://www.law360.com/articles/52154 http://www.law360.com/articles/51710 A federal judge has denied Cordis Corp.'s request to move a consolidated patent dispute filed by rival Medtronic Inc. from Texas to California. http://www.law360.com/articles/51710 http://www.law360.com/articles/41845 Four years and a few antitrust claims after it was filed, Medtronic Inc.'s coronary stent patent suit is gearing up for trial with a list of what Medtronic wants the Dallas court to prevent Cordis Corp. from mentioning in the courtroom. http://www.law360.com/articles/41845